MedPath

The efffect of herbal and animal omega-3 fatty acids on polycystic ovary syndrome

Phase 2
Conditions
Polycystic ovarian syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT2016041612438N19
Lead Sponsor
Barij Research Center of Medicinal Herbs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
105
Inclusion Criteria

patients with PCOS according to Rotterdam criteria; higher than 5 years of their disease; aged 18 to 40 years. Exclusion criterion: unwillingness to cooperate.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hirsutism. Timepoint: Baseline and End-of-trial. Method of measurement: Observation.;Insulin resistance. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Insulin. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Testosterone. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Prolactin. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Follicular- stimulating hormone. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Acne. Timepoint: Baseline and End-of-trial. Method of measurement: Observation.;Lipid profile. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.;Hair loss. Timepoint: Baseline and End-of-trial. Method of measurement: Observation.;DHEAs. Timepoint: Baseline and End-of-trial. Method of measurement: Blood sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath